Abigail Renoux

Abbie Renoux is a Principal Scientist at Vigil Neuroscience, with previous experience as a Senior Scientist at Triplet Therapeutics. Abbie's expertise lies in cell biology assay development for trinucleotide repeat disorders. Prior to their current roles, Abbie held positions at Proclara Biosciences, Tufts University, and the University of Michigan, where they conducted research in neuroscience and molecular and integrative physiology. Abbie holds a PhD in Molecular and Integrative Physiology from the University of Michigan and a Bachelor of Science in MCDB and Biochemistry from the University of Colorado Boulder.